1st December 2017, Volume 130 Number 1466

Thasvir Singh, Kavin Andi

Fanconi anaemia (FA) is a rare hereditary genetic disorder with an incidence of approximately 1–5 per million births, although it is more common among Ashkenazi Jews and black South Africans.1…

Subscriber content

The full contents of this page is only available to subscribers.

To view this content please login or subscribe

Abstract

Fanconi anaemia (FA) is a rare multi-system genetic disorder where patients are susceptible to the development of oral malignancies. Clinicians involved in their management should be vigilant in detecting lesions early, and an individualised treatment plan should then be formulated. Although surgery forms the mainstay of oncological treatment, adjuvant therapy can be instituted with care. Unfortunately, prognosis is poor, and close long-term follow-up is required. This short report describes pertinent management considerations in relation to a case of oral squamous cell carcinoma.

Author Information

Thasvir Singh, Oral and Maxillofacial Surgery, Waikato District Health Board, Hamilton;
Kavin Andi, Department of Maxillofacial Surgery, St George’s Hospital, London, United Kingdom.

Acknowledgements

The authors would like to acknowledge the contributions of Dr P Henry (Oral and Maxillofacial Surgery Department) and Dr P Wilson (Pathology Department). There were no commercial associations or external financial funding used in the production of this case report.

Correspondence

Thasvir Singh, Oral and Maxillofacial Surgery, Waikato District Health Board, Pembroke Street, Hamilton.

Correspondence Email

thasvir.singh@waikatodhb.health.nz

Competing Interests

Nil.

References

  1. Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet 2001; 2:446–57. 
  2. Wong WM, Parvathaneni U, Jewell PD, Martins RG, Futran ND, Laramore GE, Liao JJ. Squamous cell carcinoma of the oral tongue in a patient with Fanconi anemia treated with radiotherapy and concurrent cetuximab: A case report and review of the literature. Head Neck 2013: 35:E292-8. DOI 10.1002/hed.23155 
  3. Lee HJ, Park S, Kang HJ, Jun JK, Lee JA, Lee DS, Park SS, Seong MW. A case report of Fanconi anemia diagnosed by genetic testing followed by prenatal diagnosis. Ann Lab Med 2012; 32:380–84.
  4. Kaplan MJ, Sabio H, Wanebo HJ, Cantrell RW. Squamous cell carcinoma in the immunosuppressed patient: Fanconi›s anemia. Laryngoscope 1985; 95:771–75.
  5. Rosenberg PS, Socie G, Alter BP, Gluckman E. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 2005; 105:67–73.
  6. Kutler DI, Auerbach AD, Satagopan J, Giampietro PF, Batish SD, Huvos AG, Goberdhan A, Shah JP, Singh B. High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg 2003; 129:106–12. 
  7. Masserot C, Peffault de Latour R, Rocha V, Leblanc T, Rigolet A, Pascal F, Janin A, Soulier J, Gluckman E, Socié G. Head and neck squamous cell carcinoma in 13 patients With Fanconi anemia after hematopoietic stem cell transplantation. Cancer 2008; 113:3315–22.
  8. Kutler DI, Wreesmann VB, Goberdhan A, et al. Human Papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anaemia patients. J Natl Cancer Inst 2003; 95:1718–21.
  9. Sauter SL, Wells SI, Zhang X, et al. Oral human papillomavirus is common in individuals with Fanconia anaemia. Cancer Epidemiol Biomarkers Prev 2015; 24:864–72.
  10. Carroll T, Vora A, McMahon J. Standards of Care for Fanconi Anaemia affected Individuals and their Families. UK & Ireland Fanconi Anaemia Clinical Network, 2008. Clin Oncol 2010; 22:898.
  11. Alter BP. Cancer in Fanconi anemia, 1927–2001. Cancer 2003; 97:425–40. 
  12. D’Andrea AD. Susceptibility pathways in Fanconi’s anemia and breast cancer. N Engl J Med 2010; 362:1909–19.
  13. Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF, Hanenberg H, Auerbach AD. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003; 101:1249–56.
  14. Schethenbach K, Wagenmann M, Freund M, Schipper J, Hanenberg H. Squamous Cell Carcinomas of the Head and Neck in Fanconi Anemia: Risk, Prevention, Therapy, and the Need for Guidelines. Klin Padiatr 2012; 224:132–138.

Download

The downloadable PDF version of this article is only available to subscribers.

To view this content please login or subscribe